KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Income from Continuing Operations: 2009-2014

Historic Income from Continuing Operations for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$50.7 million.

  • Biocryst Pharmaceuticals' Income from Continuing Operations fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Income from Continuing Operations stood at -$50.7 million for FY2014, which was down 43.14% from -$35.4 million recorded in FY2013.
  • Biocryst Pharmaceuticals' Income from Continuing Operations' 5-year high stood at -$33.9 million during FY2010, with a 5-year trough of -$52.9 million in FY2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Income from Continuing Operations averaged around -$41.5 million, with its median value being -$38.3 million (2012).
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Income from Continuing Operations tumbled by 151.68% in 2010, and later rose by 27.60% in 2012.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Income from Continuing Operations stood at -$33.9 million in 2010, then plummeted by 56.41% to -$52.9 million in 2011, then increased by 27.60% to -$38.3 million in 2012, then climbed by 7.64% to -$35.4 million in 2013, then plummeted by 43.14% to -$50.7 million in 2014.